Pacific Biosciences of California, Inc. Amortization
Pacific Biosciences of California, Inc. (PACB) reported Amortization of $369.40 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AdjustmentForAmortization · last filed 2026-02-25
- Pacific Biosciences of California, Inc. amortization for fiscal 2025 was $369.40M, a 1248.18% increase from fiscal 2024.
- Pacific Biosciences of California, Inc. amortization for fiscal 2024 was $27.40M, a 230.12% increase from fiscal 2023.
- Pacific Biosciences of California, Inc. amortization for fiscal 2023 was $8.30M, a 822.22% increase from fiscal 2022.
- Pacific Biosciences of California, Inc. amortization for fiscal 2022 was $900.00K, a 125.00% increase from fiscal 2021.
| Period end | Amortization 12 month |
|---|---|
| 2025-12-31 | $369.40M 10-K · filed 2026-02-25 |
| 2024-12-31 | $27.40M 10-K · filed 2026-02-25 |
| 2023-12-31 | $8.30M 10-K · filed 2026-02-25 |
| 2022-12-31 | $900.00K 10-K · filed 2025-03-17 |
| 2021-12-31 | $400.00K 10-K · filed 2024-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |